Trebananib Completed Phase 2 Trials for Malignancies / Carcinoma NOS / Metastases / Metastatic Colorectal Cancers / Malignant Neoplasm of Colon / Colorectal Cancers / Rectal Carcinoma / Metastatic Cancers / Gastrointestinal Cancers / Oncology Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00752570A Phase 2, Randomized, Double Blind, Placebo Controlled Study of AMG 386 in Combination With FOLFIRI in Subjects With Previously Treated Metastatic Colorectal Carcinoma
NCT00583674Phase 2 Study of AMG 386 (20060439) in Combination With Cisplatin & Capecitabine in Subjects With Metastatic Gastric, Gastroesophageal Junction, or Distal Esophageal Adenocarcinoma